Fundz

Revalia Bio has raised $14.5M in a Seed round to launch a Human Data Trial Platform aimed at redefining drug development.

PRIVATESep 04, 2025

Amount Raised

$14.5 Million

Round Type

Seed

New HavenBiotechnologyresearch

Investors

Roger FergusonSierra Ventures

Description

Revalia Bio has successfully raised $14.5 million in a Seed funding round. The funding will be used to launch its Human Data Trial Platform. This innovative platform aims to redefine drug development processes. The investment reflects strong confidence in Revalia Bio's vision for the future of drug trials.

Quick answer

Revalia Bio raised $14.5 Million in a Seed round, dated September 4, 2025. Investors: Roger Ferguson and Sierra Ventures. Revalia Bio is based in New Haven, Connecticut, United States.

How much did Revalia Bio raise?
Revalia Bio raised $14.5 Million in a Seed round on September 4, 2025.
Who invested in Revalia Bio?
Roger Ferguson and Sierra Ventures are named as investors in this round.
What does Revalia Bio do?
Revalia Bio is transforming loss of a loved one into profound change in the world.
Where is Revalia Bio based and how big is it?
Revalia Bio is based in New Haven, Connecticut, United States. Fundz records about 25 employees.
Who are the decision-makers at Revalia Bio?
Fundz holds 1 contact at Revalia Bio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in research and Biotechnology around the same time

Companies in the same sectors as Revalia Bio that raised within 45 days of this round, from Fundz verified event records.

  • Bexorg raised $23M (Series A) on October 16, 2025.
  • Akari Therapeutics raised $6.3M on October 16, 2025.
  • Adcytherix raised $122M (Series A) on October 16, 2025.
  • Kardigan raised $254M (Series B) on October 14, 2025.
  • Expedition Therapeutics raised $165M (Series A) on October 9, 2025.
  • BioRestorative Therapies raised $14M (Seed) on October 8, 2025.

Who to call at Revalia Bio, and when

A new round usually means Revalia Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Revalia Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Revalia Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Revalia Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Revalia Bio

Location

55 CHURCH STREET

New Haven, Connecticut, United States

About

Revalia Bio is transforming loss of a loved one into profound change in the world. We believe that organ donation for groundbreaking research holds the key to revolutionizing biomedical innovation. Because every donated organ provides a window into human health and disease that can unlock the rapid development of major medical breakthroughs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Revalia Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Revalia Bio's next move

See what Strategic adds

Revalia Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.